Family study of non-medullary thyroid cancer and genetics
Part of Cancer clinical trials.
This study looks at families affected by non-medullary thyroid cancer to understand patterns and possible genetic risk. You may be able to join even if you personally do not have the cancer, as long as you have the right family history and can complete a questionnaire.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 7 or older (child or adult)
- Have a close family link: either 1 or 2 first-degree relatives with non-medullary thyroid cancer
- You may join if you have the cancer, or if you are an unaffected family member in a cancer-affected family
- Be able to understand the study and (if required) sign the consent form
- Be able and willing to complete a family history questionnaire
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows children and adults with medullary thyroid cancer (MTC) and/or MEN2 to better understand how the condition progresses over time. It may help doctors plan care in the future by collecting long-term health and lab information, not by giving a new treatment.
This study looks at people who have rare or unusual cancers or who may have an inherited (family) risk for cancer. It helps researchers learn what genetic or other factors might be involved by collecting family history and medical records, including pathology slides.
This study looks at whether thyroid cancer or thyroid lumps can run in families due to inherited (genetic) risk. It may help researchers better identify who is at higher risk and guide future screening or prevention.
This trial follows people with medullary thyroid cancer to better understand their experiences. You may join if you have this diagnosis, are 18 or older, and are not taking another experimental drug.
This study looks at DNA (genetic information) from people and families who may have an inherited risk for cancer. It aims to find new genetic markers that can help explain cancer risk and guide future care.
This study looks at the genes and mutations in thyroid cancers that start in follicular cells. It aims to understand how these changes relate to how aggressive the cancer is.
Hear when a new Non-Medullary Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.